CE - Cochrane's Corner

Internal and Emergency Medicine

, Volume 3, Issue 1, pp 53-56

First online:

Rimonabant for overweight and “metabolic syndrome”: the attempt to supersize disease and risk by pharmaceutical marketing

  • Rita BanziAffiliated withItalian Cochrane Centre, Mario Negri Institute for Pharmacological Research
  • , Lorenzo MojaAffiliated withItalian Cochrane Centre, Mario Negri Institute for Pharmacological Research Email author 
  • , Ivan MoschettiAffiliated withItalian Cochrane Centre, Mario Negri Institute for Pharmacological Research
  • , Alessandro LiberatiAffiliated withItalian Cochrane Centre, Mario Negri Institute for Pharmacological Research
  • , Gian Franco GensiniAffiliated withDepartment of Critical Care Medicine and Surgery, University of Florence and Azienda Ospedaliero-Universitaria Careggi
  • , Roberto GusinuAffiliated withDAI Cardiologico e dei Vasi, Azienda Ospedaliero-Universitaria Careggi
  • , Andrea A. ContiAffiliated withDepartment of Critical Care Medicine and Surgery, University of Florence and Don Carlo Gnocchi Foundation IRCCS

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access